Basic and clinical research in oncology: is there background for a breakthrough?
<p>The appearance of anticancer drugs dramatically changed cancer treatment, allowing patients with a number of previously fatal diseases to achieve cure and prolong life in patients with incurable tumors. More than 100 anticancer drugs registered to date, many of which have been<br />developed in recent years using the latest advances in tumors molecular biology. At the same time the price of new anticancer drugs increases<br />much faster than efficacy of anticancer therapy. The situation is due largely to the fact that the current system of introduction of new anticancer drugs not performing initial tasks.</p
malignant tumors, cancer therapy, clinical trials, treatment standards, pharmacoeconomics, Diseases of the blood and blood-forming organs, RC633-647.5
Sorry, we are unable to provide the full text but you may find it at the following location(s):
https://doaj.org/toc/2413-4023 (external link)
https://doaj.org/toc/1818-8346 (external link)
http://oncohematology.abvpress... (external link)
https://doaj.org/article/beb23... (external link)